Anti-PLA 2R Negatif Membranöz Nefropatili İleri Yaş Hastada Pankreas Kanseri: Olgu Sunumu

Öz

İdiyopatik Membranöz Nefropatide dolaşımda tesbit edilen anti-PLA2R otoantikorları saptanmayan yeni tanı almış Membranöz Nefropatili ileri yaş hastalarda okkult malignite ısrarla aranmalıdır. Biz Anti-PLA 2R negatif,65 yaşındaki nefrotik sendromlu bayan hastada malignite taramasıyla tesbit ettiğimiz pankreas kanseri vakasını bildiriyoruz

Anahtar Kelimeler

• Anti-PLA2R antibodies

Pancreatic Cancer in an Elderly with Anti-PLA 2R Negative Membranous Nephropathy: Case Report

Abstract

In Patients with newly diagnosed Membranous Nephropathy in advanced age with the absence of Anti-PLA2R antibodies in their circulation, must be evaluated thoroughly for occult malignancy. We are reporting a anti-PLA2R negative 65 years old female nephrotic sydrome patient who was diagnosed with pancreatic cancer while being scanned for maligencies.

Keywords

• Anti-PLA2R antibodies

Kaynakça

1. 1. Swaminathan S, Leung N, Lager DJ, Melton LJ 3rd, Bergstralh EJ, Rohlinger A, Fervenza FC: Changing incidence of glomerular disease in OlmstedCounty, Minnesota: a 30-year renal biopsy study. Clin J Am SocNephrol 2006; 1: 483-487.
2. 2. Ponticelli C, Glassock RJ: Glomerular diseases: membranous nephropathy - a modern view. Clin J Am Soc Nephrol 2014;9:609-616.
3. 3. Lee JC, Yamauchi H, Hopper J Jr: Theassociation of cancer and the nephrotic syndrome. Ann Intern Med 1966;64:41-51.
4. 4. Leeaphorn N, Kue-A-Pai P, Thamcharoen N, Ungprasert P, Stokes MB, Knight EL. Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies. Am J Nephrol. 2014;40(1):29-35. doi: 10.1159/0003 64782.
5. 5. Lefaucheur C, Stengel B, Nochy D, Martel P, Hill GS, Jacquot C, Rossert J, GN-PROGRESS StudyGroup: Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association. KidneyInt 2006;70:1510-1517.